Telix Pharmaceuticals | TLX - 市值



金融业
股票价格
AUD
资产
AUD 1.16B
现金及等价物
AUD 207.16M
销售成本
AUD 221.36M
流动资产
AUD 330.28M
流动负债
AUD 231.62M
债务
AUD 418.25M
EBIT
AUD 8.04M
EBITDA
AUD 18.42M
EPS每股收益
AUD -0.05
股本和储备
AUD 416.86M
销售毛利
AUD 217.82M
债务利息支出
AUD 7.62M
利息收入
AUD 1.37M
贷款资金
AUD 448.45M
市值
AUD 5.08B
净收入
AUD -4.83M
营业费用
AUD 405.4M
营业利润
AUD 8.04M
普通股股本
AUD 338.78M
PE价格收益
244.46
税前利润
AUD 76.73M
销售收入
AUD 413.44M
销售和管理费用
AUD 93.48M
股票
AUD 35.23M
贸易债权人
AUD 71.66M
应收帐款人
AUD 135.25M


市值 更改 日
Cochlear AUD 17.05B 2.6B 2025-12
CSL USD 55.89B 20.42B 2025-12
Integral Diagnostics AUD 1.08B 457.31M 2024-12
Mayne Pharma AUD 252.67M 153.55M 2025-12
Medical Developments International AUD 62.53M 563.29K 2025-12
Mesoblast USD 2.34B 9.04M 2026-06
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Pacific Edge NZD 177.94M 49.22M 2026-06
Paradigm Biopharmaceuticals AUD 145.7M 26.92M 2025-12
Polynovo AUD 849.74M 24.18M 2025-12
PYC Therapeutics AUD 965.3M 209.97M 2025-12
Ramsay Health Care AUD 7.93B 537.83M 2025-12
ResMed USD 52.52B 12.57B 2025-12
Sonic Healthcare AUD 11.17B 1.7B 2025-12